Decision aid development and its acceptability among adults with attention-deficit/hyperactivity disorders regarding treatment discontinuation after remission.

Noa TsujiiTakashi OkadaMasahide UsamiHidenori KuwabaraJunichi FujitaHideki NegoroJunzo IidaYumi AokiYoshikazu TakaesuTakuya Saito

Published in: PCN reports : psychiatry and clinical neurosciences (2022)

Our results could facilitate the SDM process between patients and healthcare providers on the continuation or discontinuation of ADHD medication following remission. Further studies should verify the effects of using the DA during the SDM process among patients across the age spectrum with ADHD and healthcare providers.

Keyphrases

healthcare
working memory
attention deficit hyperactivity disorder
autism spectrum disorder
end stage renal disease
ejection fraction
newly diagnosed
disease activity
prognostic factors
ulcerative colitis
emergency department
rheumatoid arthritis
health insurance